The global single-use bioprocessing market is expected to exceed US$ 5.44 billion by 2022, registering a compound annual growth rate (CAGR) of 17.8% during the forecast period. The increasing demand for biopharmaceuticals, lower costs and lesser environmental impact on single-use bioprocessing technologies, faster implementation and lower risk of product cross-contamination are expected to drive the market. However, issues related to leachables, extractables, scalability, and waste disposables are hampering the market.
In this report, the global single-use bioprocessing market is segmented by application, end user, product, and region. The market on the basis of application is segmented into filtration, storage, cell culture, mixing, and purification. The market in the filtration application accounted for the largest share in 2016. On the basis of end user, the market is segmented into life science R&D and biopharmaceutical manufacturers. In 2016, biopharmaceutical manufacturers were the largest end users of single-use bioprocessing. The market by product includes media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others including tubing, connectors, and samplers. The media bags and containers segment accounted for the largest share of the market in 2016
The global single-use bioprocessing market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The emerging countries of the Asia Pacific and Latin America regions are expected to drive the market during the forecast period. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional single-use bioprocessing market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
Sartorius Stedim Biotech S.A. (France), Thermo Fisher Scienctific (U.S.), Merck Millipore (Germany), GE Healthcare (U.S.), and Danaher Corporation (U.S.) are the most active players in the single-use bioprocessing market.
This report covers the single-use bioprocessing market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global single-use bioprocessing market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the single-use bioprocessing market will help customers with the identification of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com